CyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsDoxorubicinVincristineCombined Modality TherapyDisease-Free SurvivalCisplatinTreatment OutcomeOsteosarcomaChemotherapy, AdjuvantPrognosisPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Agents, AlkylatingRetrospective StudiesEtoposideMethotrexateDrug Administration ScheduleBreast NeoplasmsPhosphoramide MustardsSurvival AnalysisAntibiotics, AntineoplasticSurvival RateClinical ProtocolsPrednisonePaclitaxelNeoadjuvant TherapyAntineoplastic Agents, PhytogenicNeoplasmsDose-Response Relationship, DrugNeoplasm StagingThiotepaLymphoma, Non-HodgkinTime FactorsLung NeoplasmsImmunosuppressive AgentsBleomycinIfosfamideLeukopeniaCarboplatinCarmustineTransplantation, AutologousAntimetabolites, AntineoplasticGranulocyte Colony-Stimulating FactorCytarabinePrednisoloneTaxoidsPulse Therapy, DrugVinblastineAntibodies, Monoclonal, Murine-DerivedFollow-Up StudiesMelphalanBusulfanDrug Resistance, NeoplasmNeutropeniaHematopoietic Stem Cell TransplantationFluorouracilBone Marrow TransplantationEpirubicinNeoplasm Recurrence, LocalMitoxantroneAnthracyclinesVomitingClinical Trials as TopicCell Line, TumorOvarian NeoplasmsNeoplasm MetastasisInfusions, IntravenousRecurrenceNauseaProspective StudiesRemission InductionVidarabineInduction ChemotherapySalvage TherapyDeoxycytidineDrug Screening Assays, AntitumorLomustineDrug EvaluationOrganoplatinum CompoundsDrug SynergismWhole-Body IrradiationHodgkin DiseaseMesnaLymphomaApoptosisAdministration, MetronomicAntibodies, MonoclonalDaunorubicinAdenocarcinomaDexamethasoneDrug Therapy, CombinationThrombocytopeniaTransplantation ConditioningNeoplasm TransplantationCell SurvivalChlorambucilTumor Cells, CulturedDacarbazineRadiotherapy